News

University of East Anglia researchers make breakthrough for ‘next gen’ cancer treatment. These new treatments would be highly targeted and more effective than current state-of-the-art cancer immunotherapies. New research published today reveals the science behind this innovative idea. It shows how...

The Governments of Canada and Prince Edward Island (PEI) will invest $50 million in the BioAccelerator, the largest single investment in economic development infrastructure in PEI history. The announcement was made by Ginette Petitpas Taylor, Minister of Official Languages, who...

BioMed X unveiled its new immunology discovery platform designed to allow for the accurate and fast identification of target antigens of human T cell receptors (TCRs). The platform is expected to be deployed via a collaborative model with pharmaceutical and...

Lonza, a partner to the pharmaceutical, biotech and nutraceutical markets, has completed a planned expansion of its bioconjugation facility in Visp, Switzerland. The expansion includes two manufacturing suites and supporting infrastructure to support an extended customer portfolio, including companies entering...

A group of committed AusBiotech leaders has joined forces to create an Australian biotech first: a sector-specific environmental, social, and governance (ESG) tool in order to assist companies in attracting investment and navigating ESG reporting. The AusBiotech ESG Working Group...

Final assessments of a Phase II trial for resectable non-small cell lung cancer found that 60% of patients who had gone on to receive the neoadjuvant nivolumab remained recurrence-free five years following surgery. Overall survival rates were also found...

It has come to light that the federal health agencies have gone on to select three new models so as to lower the prices of the drugs and work on President Joe Biden’s executive order that targets the drug...